Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-24

Clinical Trial Update: Propolis Lozenges Extract and Their Effect on Salivary Biomarkers and on Oral Health Condition in (19_24) Years Old [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating propolis lozenges extract on salivary biomarkers and oral health conditions in young adults (age 19-24) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Propolis lozenges extract (propolis extract (lozenge formulation))

Snippet

Sponsor: Al-Mustansiriyah University | Conditions: Plaque Induced Gingivitis, Mouth Diseases | Phase 1 | Status: COMPLETED